Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

SourceAllSEC EDGARDOJBank of JapanWhite HouseECBFederal ReserveBank of England
TopicAllenforcementfilingsmonetarypolicy

5793 items from SEC EDGAR · clear filters

  • SEC EDGARfilings
    8-K - CRA INTERNATIONAL, INC. (0001053706) (Filer)

    CRA International, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)

    Corbus Pharmaceuticals Holdings filed a Form 8-K on August 6, 2026, containing Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).

  • SEC EDGARfilings
    8-K - Vivani Medical, Inc. (0001266806) (Filer)

    Vivani Medical, Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - HELIX ENERGY SOLUTIONS GROUP INC (0000866829) (Filer)

    Helix Energy Solutions Group Inc filed a Form 8-K on August 6 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Edgewise Therapeutics, Inc. (0001710072) (Filer)

    Edgewise Therapeutics filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - VivoSim Labs, INC. (0001497253) (Filer)

    VivoSim Labs, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)

    ALX Oncology Holdings Inc filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.

  • SEC EDGARfilings
    8-K - LIFETIME BRANDS, INC (0000874396) (Filer)

    Lifetime Brands filed an 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)

    Establishment Labs Holdings Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 reporting its results of operations and financial condition, and Item 9.01 containing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - ACI WORLDWIDE, INC. (0000935036) (Filer)

    ACI Worldwide, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - MBX Biosciences, Inc. (0001776111) (Filer)

    MBX Biosciences, Inc. filed an 8-K on August 6, 2026, containing Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGARfilings
    8-K - INSIGHT ENTERPRISES INC (0000932696) (Filer)

    Insight Enterprises Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - NOVAVAX INC (0001000694) (Filer)

    Novavax Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Aurinia Pharmaceuticals Inc. (0001600620) (Filer)

    Aurinia Pharmaceuticals filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Prime Medicine, Inc. (0001894562) (Filer)

    Prime Medicine, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing financial statements and related exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - Globalstar, Inc. (0001366868) (Filer)

    Globalstar, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - USA TODAY Co., Inc. (0001579684) (Filer)

    USA TODAY Co., Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing related financial statements and exhibits.

  • SEC EDGARfilings
    8-K - HERTZ CORP (0000047129) (Filer)

    Hertz Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Filer)

    Hertz Global Holdings, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - NextTrip, Inc. (0000788611) (Filer)

    NextTrip, Inc. filed a Form 8-K on August 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Playtika Holding Corp. (0001828016) (Filer)

    Playtika Holding Corp. filed a Form 8-K on August 6, 2026, reporting its results of operations, financial condition, and providing financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Guerrilla RF, Inc. (0001832487) (Filer)

    Guerrilla RF, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).

  • SEC EDGARfilings
    8-K - Aligos Therapeutics, Inc. (0001799448) (Filer)

    Aligos Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - Burford Capital Ltd (0001714174) (Filer)

    Burford Capital Ltd filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - RADIAN GROUP INC (0000890926) (Filer)

    Radian Group Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - MIRA PHARMACEUTICALS, INC. (0001904286) (Filer)

    Mira Pharmaceuticals, Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.

  • SEC EDGARfilings
    8-K - TEJON RANCH CO (0000096869) (Filer)

    Tejon Ranch Co filed a Form 8-K on August 6, 2026, including Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.

  • SEC EDGARfilings
    8-K - Parker-Hannifin Corp (0000076334) (Filer)

    Parker-Hannifin Corp filed a Form 8-K on August 6, 2026, reporting Item 2.02 results of operations and financial condition and Item 9.01 financial statements and exhibits.

  • SEC EDGARfilings
    8-K - AGENUS INC (0001098972) (Filer)

    Agenus Inc. filed a Form 8-K on August 6, 2026, disclosing its results of operations and financial condition for the reporting period.

  • SEC EDGARfilings
    8-K - Cars.com Inc. (0001683606) (Filer)

    Cars.com Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing related financial statements and exhibits.